BARCLAYS PLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$62
-17.3%
36,745
-5.0%
0.00%
Q2 2023$75
-62.9%
38,662
-46.8%
0.00%
Q1 2023$202
+129.5%
72,675
+186.2%
0.00%
Q4 2022$88
-99.9%
25,395
+0.7%
0.00%
Q3 2022$64,000
+18.5%
25,225
+12.9%
0.00%
Q2 2022$54,000
-56.1%
22,347
-24.7%
0.00%
Q1 2022$123,000
-93.6%
29,675
-80.0%
0.00%
Q4 2021$1,908,000
+385.5%
148,416
+307.7%
0.00%
Q3 2021$393,000
+80.3%
36,405
+52.5%
0.00%
Q2 2021$218,000
-68.6%
23,866
-67.6%
0.00%
Q1 2021$694,000
+1726.3%
73,638
+654.3%
0.00%
Q4 2020$38,000
+2.7%
9,763
-29.4%
0.00%
Q3 2020$37,000
-66.1%
13,831
-15.6%
0.00%
Q2 2020$109,000
+127.1%
16,384
+98.3%
0.00%
Q1 2020$48,000
-78.7%
8,263
-67.2%
0.00%
Q4 2019$225,000
+100.9%
25,226
+93.1%
0.00%
Q3 2019$112,000
-38.1%
13,066
-19.6%
0.00%
Q2 2019$181,000
-32.0%
16,259
-18.7%
0.00%
Q1 2019$266,000
+297.0%
20,000
+359.3%
0.00%
Q4 2018$67,000
-52.8%
4,354
-56.5%
0.00%
Q3 2018$142,00010,0000.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$41,970,0008.18%
Copernicus Capital Management, LLC 37,000$349,0005.64%
EcoR1 Capital, LLC 3,421,287$32,263,0001.43%
Palo Alto Investors LP 2,298,382$21,674,0001.24%
AlpInvest Partners B.V. 226,866$2,139,0001.06%
Stenahm Asset Managment Ltd 150,000$1,415,0001.00%
FRAZIER MANAGEMENT LLC 1,030,878$9,721,0000.78%
BVF INC/IL 1,861,239$17,551,0000.66%
Avidity Partners Management LP 2,122,064$20,011,0000.55%
Redmile Group, LLC 2,448,158$23,086,0000.32%
View complete list of GRITSTONE ONCOLOGY INC shareholders